High-throughput processing to preserve viable cells

A precision medicine initiative cohort program workshop

Rebekah S. Rasooly, Daniel R. Gossett, Marianne K. Henderson, Allison Hubel, Stephen N Thibodeau

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Conventionally, biobanks supporting clinical research studies have preserved serum, plasma, urine, saliva, a variety of tissue types, and stool. With the emergence of increasingly sophisticated technologies for analyzing single cells, there is growing interest in preserving viable blood cells for future functional studies. The new All of Us Research Program (formerly the Precision Medicine Initiative Cohort Program) biobank plans to house samples from a million or more individuals as part of a cohort with rich phenotypic data and longitudinal follow-up (www.nih.gov/research-training/allofus-research-program). Storage of viable cells for future single-cell analysis offers the promise of new biology, discovery of novel biomarkers, and advances toward the goal of precision medicine. A workshop was held in the summer of 2016 to evaluate the case for preservation of viable mononuclear blood cells and its feasibility within the collection plan for the biobank.

Original languageEnglish (US)
Pages (from-to)341-343
Number of pages3
JournalBiopreservation and Biobanking
Volume15
Issue number4
DOIs
StatePublished - Aug 1 2017

Fingerprint

Precision Medicine
Medicine
Throughput
Education
Processing
Research
Blood Cells
Blood
Cells
Single-Cell Analysis
Biomarkers
Saliva
Urine
Tissue
Technology
Plasmas
Serum

Keywords

  • biomarkers
  • cell preservation
  • cell viability
  • high-throughput
  • precision medicine
  • single-cell analysis

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Cell Biology

Cite this

High-throughput processing to preserve viable cells : A precision medicine initiative cohort program workshop. / Rasooly, Rebekah S.; Gossett, Daniel R.; Henderson, Marianne K.; Hubel, Allison; Thibodeau, Stephen N.

In: Biopreservation and Biobanking, Vol. 15, No. 4, 01.08.2017, p. 341-343.

Research output: Contribution to journalArticle

Rasooly, Rebekah S. ; Gossett, Daniel R. ; Henderson, Marianne K. ; Hubel, Allison ; Thibodeau, Stephen N. / High-throughput processing to preserve viable cells : A precision medicine initiative cohort program workshop. In: Biopreservation and Biobanking. 2017 ; Vol. 15, No. 4. pp. 341-343.
@article{2d74a763d82a4e208c137e8b1039c2d0,
title = "High-throughput processing to preserve viable cells: A precision medicine initiative cohort program workshop",
abstract = "Conventionally, biobanks supporting clinical research studies have preserved serum, plasma, urine, saliva, a variety of tissue types, and stool. With the emergence of increasingly sophisticated technologies for analyzing single cells, there is growing interest in preserving viable blood cells for future functional studies. The new All of Us Research Program (formerly the Precision Medicine Initiative Cohort Program) biobank plans to house samples from a million or more individuals as part of a cohort with rich phenotypic data and longitudinal follow-up (www.nih.gov/research-training/allofus-research-program). Storage of viable cells for future single-cell analysis offers the promise of new biology, discovery of novel biomarkers, and advances toward the goal of precision medicine. A workshop was held in the summer of 2016 to evaluate the case for preservation of viable mononuclear blood cells and its feasibility within the collection plan for the biobank.",
keywords = "biomarkers, cell preservation, cell viability, high-throughput, precision medicine, single-cell analysis",
author = "Rasooly, {Rebekah S.} and Gossett, {Daniel R.} and Henderson, {Marianne K.} and Allison Hubel and Thibodeau, {Stephen N}",
year = "2017",
month = "8",
day = "1",
doi = "10.1089/bio.2017.0016",
language = "English (US)",
volume = "15",
pages = "341--343",
journal = "Biopreservation and Biobanking",
issn = "1947-5535",
publisher = "Mary Ann Liebert Inc.",
number = "4",

}

TY - JOUR

T1 - High-throughput processing to preserve viable cells

T2 - A precision medicine initiative cohort program workshop

AU - Rasooly, Rebekah S.

AU - Gossett, Daniel R.

AU - Henderson, Marianne K.

AU - Hubel, Allison

AU - Thibodeau, Stephen N

PY - 2017/8/1

Y1 - 2017/8/1

N2 - Conventionally, biobanks supporting clinical research studies have preserved serum, plasma, urine, saliva, a variety of tissue types, and stool. With the emergence of increasingly sophisticated technologies for analyzing single cells, there is growing interest in preserving viable blood cells for future functional studies. The new All of Us Research Program (formerly the Precision Medicine Initiative Cohort Program) biobank plans to house samples from a million or more individuals as part of a cohort with rich phenotypic data and longitudinal follow-up (www.nih.gov/research-training/allofus-research-program). Storage of viable cells for future single-cell analysis offers the promise of new biology, discovery of novel biomarkers, and advances toward the goal of precision medicine. A workshop was held in the summer of 2016 to evaluate the case for preservation of viable mononuclear blood cells and its feasibility within the collection plan for the biobank.

AB - Conventionally, biobanks supporting clinical research studies have preserved serum, plasma, urine, saliva, a variety of tissue types, and stool. With the emergence of increasingly sophisticated technologies for analyzing single cells, there is growing interest in preserving viable blood cells for future functional studies. The new All of Us Research Program (formerly the Precision Medicine Initiative Cohort Program) biobank plans to house samples from a million or more individuals as part of a cohort with rich phenotypic data and longitudinal follow-up (www.nih.gov/research-training/allofus-research-program). Storage of viable cells for future single-cell analysis offers the promise of new biology, discovery of novel biomarkers, and advances toward the goal of precision medicine. A workshop was held in the summer of 2016 to evaluate the case for preservation of viable mononuclear blood cells and its feasibility within the collection plan for the biobank.

KW - biomarkers

KW - cell preservation

KW - cell viability

KW - high-throughput

KW - precision medicine

KW - single-cell analysis

UR - http://www.scopus.com/inward/record.url?scp=85027221276&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85027221276&partnerID=8YFLogxK

U2 - 10.1089/bio.2017.0016

DO - 10.1089/bio.2017.0016

M3 - Article

VL - 15

SP - 341

EP - 343

JO - Biopreservation and Biobanking

JF - Biopreservation and Biobanking

SN - 1947-5535

IS - 4

ER -